Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Conneqt HealthCQTHF 37 EV-to-EBITDA is -1.16 as of Aug. 14, 2026. GuruFocus rates CQTHF with a GF Score™ of 37/100 and a GF Value™ of $0.71. The stock has 8 warning signs investors should review. Among 515 Medical Devices & Instruments companies, Conneqt Health ranks worse than 194174.56% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Conneqt Health's enterprise value is $12.70 Mil.
Conneqt Health's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was $-10.93 Mil. Therefore, Conneqt Health's EV-to-EBITDA for today is -1.16.
The historical rank and industry rank for Conneqt Health's EV-to-EBITDA or its related term are showing as below:
CQTHF'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -23.71 Med: -2.69 Max: -0.27
Current: -1.08
During the past 13 years, the highest EV-to-EBITDA of Conneqt Health was -0.27. The lowest was -23.71. And the median was -2.69.
CQTHF's EV-to-EBITDA is ranked worse than 100% of 515
companies
in the Medical Devices & Instruments industry
Industry Median: 14.89
vs CQTHF: -1.08
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Conneqt Health (OTCPK:CQTHF) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Conneqt Health's PE Ratio (TTM) for today is calculated as:
Conneqt Health's share price for today is $0.40.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Conneqt Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $-0.025.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Conneqt Health's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Conneqt Health's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Conneqt Health EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Conneqt Health's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Conneqt Health's EV-to-EBITDA falls into.
Conneqt Health's current Enterprise Value is $12.70 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Conneqt Health's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was $-10.93 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Conneqt Health (CQTHF) has a EV-to-EBITDA of -1.16 as of Aug. 14, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Conneqt Health. According to the industry distribution chart, Conneqt Health ranks #999999 out of 515 companies in the Medical Devices & Instruments industry.
Is Conneqt Health's EV-to-EBITDA too high?
Conneqt Health's current EV-to-EBITDA is -1.16. Based on the distribution chart, Conneqt Health ranks #999999 out of 515 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Conneqt Health has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Conneqt Health's EV-to-EBITDA compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Conneqt Health ranks #999999 out of 515 companies for EV-to-EBITDA. This places Conneqt Health in the lower half of its industry. The industry median EV-to-EBITDA is 14.89. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.89, based on 515 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Conneqt Health. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Conneqt Health's current EV-to-EBITDA is -1.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Conneqt Health stock overvalued right now?
Conneqt Health (CQTHF) has a current EV-to-EBITDA of -1.16. The stock's GF Value™ is $0.71, compared to a current price of $0.40 — trading 43.7% below its estimated fair value. The current EV-to-EBITDA is -1.16. Conneqt Health's overall GF Score™ is 37/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Conneqt Health (CQTHF), the current EV-to-EBITDA is -1.16 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Conneqt Health (CQTHF) Overvalued in 2026?
Based on GuruFocus' analysis, Conneqt Health stock appears to be undervalued.
The current stock price of $0.40 is trading 43.7% below its estimated GF Value™ of $0.71.
Key valuation signals for CQTHF:
EV-to-EBITDA: -1.16
GF Value™: $0.71 vs. price of $0.40 (43.7% below fair value)
No single metric tells the full story. See the CQTHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Conneqt Health Ltd is a health technology company, developing solutions for health disorders. The company designs medical devices for use in cardiovascular health management. The company is mainly engaged in manufacturing biomarkers that helps to detect associated risks, optimize heart health, and empower good cardiovascular decisions.
37GF Score
Get the complete analysis for CQTHF
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CQTHF has been successfully added to your 
